User profiles for Nebojsa Janjic

Nebojsa Janjic

Verified email at somalogic.com
Cited by 14631

Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor

…, LA Beebe, BD Feistner, SC Gill, FM Jucker, N Janjić - Chemistry & biology, 1995 - cell.com
Background: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is a
potent inducer of new blood vessel growth (angiogenesis) that contributes to the pathology …

Liposome-anchored vascular endothelial growth factor aptamers

…, S Knauer, RA Bendele, PS Gill, N Janjić - Bioconjugate …, 1998 - ACS Publications
Nuclease-resistant aptamers identified from randomized nucleic acid libraries represent a
novel class of drug candidates. Aptamers are synthesized chemically and therefore can be …

Aptamer-based multiplexed proteomic technology for biomarker discovery

…, J Heil, J Heilig, B Hicke, G Husar, N Janjic… - Nature …, 2010 - nature.com
Interrogation of the human proteome in a highly multiplexed and efficient manner remains a
coveted and challenging goal in biology. We present a new aptamer-based proteomic …

Genomic atlas of the human plasma proteome

…, SL Spain, AM Wood, NW Morrell, JR Bradley, N Janjic… - Nature, 2018 - nature.com
Although plasma proteins have important roles in biological processes and are the direct
targets of many drugs, the genetic factors that control inter-individual variation in plasma …

[HTML][HTML] 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165): Inhibition of receptor binding and …

…, DD Henninger, L Claesson-Welsh, N Janjic - Journal of Biological …, 1998 - ASBMB
Vascular endothelial growth factor (VEGF) has been implicated in the pathological induction
of new blood vessel growth in a variety of proliferative disorders. Using the SELEX process (…

Inhibitory DNA ligands to platelet-derived growth factor B-chain

…, R Jenison, A Östman, CH Heldin, N Janjic - Biochemistry, 1996 - ACS Publications
We have identified a group of DNA molecules that bind to platelet-derived growth factor (PDGF)-AB
with subnanomolar affinity from a randomized DNA library using in vitro selection. …

[HTML][HTML] Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents

…, UA Ochsner, DJ Schneider, L Gold, N Janjic - … Therapy-Nucleic Acids, 2014 - cell.com
Limited chemical diversity of nucleic acid libraries has long been suspected to be a major
constraining factor in the overall success of SELEX (Systematic Evolution of Ligands by …

[HTML][HTML] VEGF165 mediates glomerular endothelial repair

…, D Kerjaschki, DD Henninger, N Janjic… - The Journal of …, 1999 - Am Soc Clin Investig
VEGF 165 , the most abundant isoform in man, is an angiogenic cytokine that also regulates
vascular permeability. Its function in the renal glomerulus, where it is expressed in visceral …

Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor

D Jellinek, LS Green, C Bell, N Janjic - Biochemistry, 1994 - ACS Publications
Revised Manuscript Received May 17, 1994® abstract: The proliferation of new blood vessels
(angiogenesis) is a process that accompanies many pathological conditions including …

Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers

…, C Vargeese, SC Gill, LS Green, N Janjic - The American journal of …, 1999 - Elsevier
Mesangial cell proliferation and matrix accumulation, driven by platelet-derived growth factor
(PDGF), contribute to many progressive renal diseases. In a novel approach to antagonize …